Skip to content

Clinical trials

Observational Fabry Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Phase: Observational Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20022
20031
20042
20051
20073
20082
20094
20108
20114
20123
20131
20146
20155
20166
20173
20186
20197
20207
20218
20225
202316
20246
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Unknown status30
Recruiting26
Terminated6
Withdrawn5
Active, not recruiting4
Not yet recruiting3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CENTOGENE GmbH Rostock6
National Institute of Neurological Disorders and Stroke (NINDS)6
Yonsei University5
Amicus Therapeutics4
IRCCS Azienda Ospedaliero-Universitaria di Bologna4
Caroline Michaela Kistorp3
Chiesi Farmaceutici S.p.A.3
O & O Alpan LLC3
Shire3
Amicus Therapeutics France SAS2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease127
Stroke10
Cardiomyopathy, Hypertrophic8
Lysosomal Storage Diseases7
Renal Insufficiency, Chronic7
Cardiomyopathies6
Amyloid Neuropathies, Familial5
Gaucher Disease5
Hypertrophy, Left Ventricular5
Rare Diseases5

Trials

Showing 26 to 50 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.